Vprazo – Glenmark Pharmaceuticals

Opposed App ID 6051918 Class 5 Word

Trademark information

IP India · live record
Application ID
6051918
Status
Opposed
Sub status
Not Applicable
Date of application
04 August 2023
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
—

Goods & services

Class 5

Class 5PHARMACEUTICAL, MEDICINAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS, NUTRACEUTICAL PREPARATIONS FOR THERAPEUTIC OR MEDICAL PURPOSES, NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 04 Aug 2023
2 TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) 08 Aug 2023
3 Journal Copy 22 Nov 2023
4 TM-O(NOTICE OF OPPOSITION) 07 Mar 2024
5 TM-O(NOTICE OF OPPOSITION) 08 Mar 2024
6 Annexure -1 under rule 46 24 Dec 2024
6 Evidence Affidavit Under Rule 46 (TOP) 24 Dec 2024
7 Annexure -1 under rule 46 24 Dec 2024
7 Evidence Affidavit Under Rule 46 (TOP) 24 Dec 2024
8 Annexure -1 under rule 46 31 Dec 2024
8 Evidence Affidavit Under Rule 46 (TOP) 31 Dec 2024
9 Annexure -1 under rule 46 31 Dec 2024
9 Evidence Affidavit Under Rule 46 (TOP) 31 Dec 2024

Correspondence and notices

1 Opposition Notice 17743750 · 6639757 18 Mar 2024
2 Opposition Counter Statement 18803873 · 6897100 04 Sep 2024
3 Opposition Notice 18803883 · 6897102 04 Sep 2024
4 Opposition Counter Statement 18803902 · 6897103 04 Sep 2024

Frequently asked questions

Vprazo was applied for on 04 August 2023.

The application was filed by Glenmark Pharmaceuticals.

Class 5.

As per IP India, the status is Opposed.

The listed application ID of Vprazo is 6051918.

Trademark attorney Vishesh And Associates.